Evidence map›Paper›PMID 23376243›Full record

Trial reportMechanisms of ageing and development2013

Discovery of novel non-synonymous SNP variants in 988 candidate genes from 6 centenarians by target capture and next-generation sequencing.

Jeehae Han, Seungjin Ryu, David M Moskowitz, Devorah Rothenberg, Daniel J Leahy, Gil Atzmon, Nir Barzilai, Yousin Suh

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Mechanisms of ageing and development, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Longevity, Centenarians and Modified Cellular Proteodynamics.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Epigenetics: Linking Nutrition to Molecular Mechanisms in Aging.Preventive nutrition and food science · 2017
    Review
  9. Article
  10. Article
  11. Genome maintenance and human longevity.Current opinion in genetics & development · 2014
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jeehae HanDepartment of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Seungjin Ryu
David M Moskowitz
Devorah Rothenberg
Daniel J Leahy
Gil Atzmon
Nir Barzilai
Yousin Suh
Albert Einstein College of Medicine · USJohns Hopkins University · USStanford University · US

Funding

THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
STATISTICS AND DATA MANAGEMENT COREP01AG027734 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BARZILAI, NIR J · 2007 to 2012
$9.3M
Structural Studies of Growth Factor Receptor FunctionR01GM099321 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI LEAHY, DANIEL J · 2011 to 2018
$2.6M
Structural Studies of Growth Factor Receptor FunctionR01CA090466 · NCI · JOHNS HOPKINS UNIVERSITY · PI LEAHY, DANIEL J · 2002 to 2010
$2.0M
Association Analysis- SNPs in Longevity Assurance GenesR01AG024391 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SUH, YOUSIN · 2004 to 2008
$1.6M
NCI NIH HHS R01 CA090466NIA NIH HHS AG024391NIA NIH HHS AG027734NIA NIH HHS AG17242NIA NIH HHS P01 AG017242NIA NIH HHS P01 AG027734NIA NIH HHS R01 AG024391NIGMS NIH HHS R01 GM099321
6 · The paper itself

Abstract

Despite evidence of a substantial genetic component, the genetic factors that underlie longevity in humans remain to be identified. Previous genome-wide linkage and association studies have not found strong evidence for the contribution of common variants besides the APOE gene, suggesting the role of rare variants in human longevity. To discover rare variants that might contribute to longevity, we selected 988 candidate genes and performed a pilot study to identify novel non-synonymous variants in 6 Ashkenazi Jewish centenarians older than 105. Our candidate genes act in pathways implicated in aging and longevity, including neurodegeneration, cognitive function, lipid metabolism, DNA repair, and genome maintenance. By implementing custom-designed Agilent SureSelect target capture and next-generation sequencing, we discovered a total of 89 novel non-synonymous SNPs (nsSNPs) and validated 51 nsSNPs by iPLEX MassArray assays. Genotyping analysis of these novel SNPs in 410 Ashkenazi Jewish controls and 390 centenarians showed significant enrichment (5.3 fold, p = 0.02) of the p.Y318C variant in PMS2 and significant depletion (7.5 fold, p = 0.04) of the p.V465A variant in GABRR3 in centenarians compared to controls. Our study presents the potential of targeted next-generation sequencing for discovery of rare but functional genetic variation which may lead to exceptional longevity in humans.

Indexed as

GenotypePolymorphism, Single NucleotideAged, 80 and overFemaleHumansLongevityMaleSequence Analysis, DNACandidate genesCentenarianFunctional variantHuman longevityTarget capture and next-generation sequencing

Identifiers

PMID23376243
PMCPMC3787996
OpenAlexW2017458537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.